Abstract
Aztreonam (SQ 26,776) is a new synthetic monocyclic beta-lactam antibiotic which is specifically active against aerobic gram-negative bacteria. High-pressure liquid chromatographic (HPLC) systems were developed for the quantitative analysis of aztreonam in human, monkey, rat, mouse, and rabbit sera and urine. The HPLC conditions employed for these analyses were a muBondapak C18 column, a mobile phase made up of 0.005 M tetrabutylammonium hydrogen sulfate at pH 3.0 and acetonitrile or methanol, UV detection at 293 nm, and a flow rate of 2.0 ml/min. For human sera and urine, the mobile phase was 80% 0.005 M tetrabutylammonium hydrogen sulfate-0.005M (NH4)2SO4 and 20% acetonitrile (vol/vol). For the range of sera and urine, HPLC analyses were shown to have excellent detector linearity of aztreonam over a concentration range of 1.0 mg/ml to 0.5 microgram/ml. Correlation coefficients for plots of aztreonam peak area versus its concentration were greater than or equal to 0.990. The detection limit of aztreonam was 1.0 micrograms/ml in sera and 5.0 micrograms/ml in urine. HPLC and microbiological assays of aztreonam in human sera and urine were in good agreement.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bonner D. P., Whitney R. R., Baughn C. O., Miller B. H., Olsen S. J., Sykes R. B. In-vivo properties of SQ 26,776. J Antimicrob Chemother. 1981 Dec;8 (Suppl E):123–130. doi: 10.1093/jac/8.suppl_e.123. [DOI] [PubMed] [Google Scholar]
- Carrol M. A., White E. R., Jancsik Z., Zarembo J. E. The determination of cephradine and cephalexin by reverse phase high-performance liquid chromatography. J Antibiot (Tokyo) 1977 May;30(5):397–403. doi: 10.7164/antibiotics.30.397. [DOI] [PubMed] [Google Scholar]
- Nakagawa T., Haginaka J., Yamaoka K., Uno T. High speed liquid chromatographic determination of cephalexin in human plasma and urine. J Antibiot (Tokyo) 1978 Aug;31(8):769–775. doi: 10.7164/antibiotics.31.769. [DOI] [PubMed] [Google Scholar]
- Swabb E. A., Leitz M. A., Pilkiewicz F. G., Sugerman A. A. Pharmacokinetics of the monobactam SQ 26,776 after single intravenous doses in healthy subjects. J Antimicrob Chemother. 1981 Dec;8 (Suppl E):131–140. doi: 10.1093/jac/8.suppl_e.131. [DOI] [PubMed] [Google Scholar]
- Swabb E. A., Sugerman A. A., Platt T. B., Pilkiewicz F. G., Frantz M. Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects. Antimicrob Agents Chemother. 1982 Jun;21(6):944–949. doi: 10.1128/aac.21.6.944. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sykes R. B., Bonner D. P., Bush K., Georgopapadakou N. H. Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria. Antimicrob Agents Chemother. 1982 Jan;21(1):85–92. doi: 10.1128/aac.21.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sykes R. B., Cimarusti C. M., Bonner D. P., Bush K., Floyd D. M., Georgopapadakou N. H., Koster W. M., Liu W. C., Parker W. L., Principe P. A. Monocyclic beta-lactam antibiotics produced by bacteria. Nature. 1981 Jun 11;291(5815):489–491. doi: 10.1038/291489a0. [DOI] [PubMed] [Google Scholar]
- Wheals B. B., Jane I. Analysis of drugs and their metabolites by high-performance liquid chromatography. A review. Analyst. 1977 Sep;102(1218):625–644. doi: 10.1039/an9770200625. [DOI] [PubMed] [Google Scholar]
- White E. R., Carroll M. A., Zarembo J. E. Reverse phase high speed liquid chromatography of antibiotics. II. Use of high efficiency small particle columns. J Antibiot (Tokyo) 1977 Oct;30(10):811–818. doi: 10.7164/antibiotics.30.811. [DOI] [PubMed] [Google Scholar]
- White E. R., Zarembo J. E. Reverse phase high speed liquid chromatography of antibiotics. III. Use of ultra high performance columns and ion-pairing techniques. J Antibiot (Tokyo) 1981 Jul;34(7):836–844. doi: 10.7164/antibiotics.34.836. [DOI] [PubMed] [Google Scholar]
- Yoshikawa T. T., Maitra S. K., Schotz M. C., Guze L. B. High-pressure liquid chromatography for quantitation of antimicrobial agents. Rev Infect Dis. 1980 Mar-Apr;2(2):169–181. doi: 10.1093/clinids/2.2.169. [DOI] [PubMed] [Google Scholar]